This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA advisers weigh safety of arthritis drugs Cox-2 class
Advisers tackle the balance between benefits and risks of Cox-2 inhibitors led by Merck Vioxx and Pfizer Celebrex and Bextra after a rise in heart attacks prompted a market withdrawal. Over three days, regulators, industry, researchers and doctors will assess what went wrong and what safeguards are needed.
MENTIONED IN THIS ARTICLE
Food and Drug Administration
Vioxx
Merck & Co
Pfizer Inc
Celebrex
Bextra